This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (9)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Movement Disorders  • Parkinson Disease/ Parkinsonian Disorders  • Alert me on articles by topic

Can an NSAID a Day Keep Parkinson Disease Away?

Arch Neurol. 2003;60:1043-1044.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

CLINICALLY APPLICABLE and effective maneuvers to protect the nervous system from selective neurodegenerative diseases have been elusive. Although the etiology and pathogenesis of Alzheimer disease (AD), amyotrophic lateral sclerosis, and idiopathic Parkinson disease (PD) are distinctly different, they share common pathogenic mechanisms in the process of neuronal cell death and degeneration. There is substantial evidence of a role for glial cell–mediated inflammation in the neurodegenerative process responsible for AD, amyotrophic lateral sclerosis, and PD.^1-3 This inflammatory response is an obvious target for potential therapeutic intervention. By far, the largest number of epidemiological studies and clinical trials analyzing the effects of modulators of inflammation (namely nonsteroidal anti-inflammatory drugs [NSAIDs],⁴ steroids, hormones, and aspirin) on disease risk,⁵ rate of progression, and cognitive function have been conducted on patients with AD. Despite the many studies, the outcomes have been inconsistent and inconclusive and have not permitted a consensus for any of these modulators . . . [Full Text of this Article]

Mya Schiess, MD
Department of Neurology, MSB 7.044
University of Texas–Houston Medical School
6341 Fannin St
Houston, TX 77030-1501
(e-mail: mya.c.schiess@uth.tmc.edu)

RELATED ARTICLE

Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease
Honglei Chen, Shumin M. Zhang, Miguel A. Hernán, Michael A. Schwarzschild, Walter C. Willett, Graham A. Colditz, Frank E. Speizer, and Alberto Ascherio
Arch Neurol. 2003;60(8):1059-1064.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease
Wahner et al.
Neurology 2007;69:1836-1842.
ABSTRACT | FULL TEXT  

Hormones Are Key Actors in Gene X Environment Interactions Programming the Vulnerability to Parkinson's Disease: Glia as a Common Final Pathway
MARCHETTI et al.
Ann. N. Y. Acad. Sci. 2005;1057:296-318.
ABSTRACT | FULL TEXT